欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号PL/V/0104/001
药品名称Duramune DAPPI+L
活性成分
    • canine adenovirus 10.0 IU
    • canine distemper virus 10.0 IU
    • canine parainfluenza virus 10.0 IU
    • canine parvovirus 10.0 IU
    • leptospira interrogans serogroup canicola 10.0 IU
    • leptospira interrogans serogroup icterohaemorragiae 10.0 IU
剂型Lyophilisate and solvent for suspension for injection
上市许可持有人Zoetis Polska Sp. z o.o. 17B Postepu 02-676 Warsaw, Poland
参考成员国 - 产品名称Poland (PL)
Duramune DAPPI+L
互认成员国 - 产品名称
    许可日期2013/11/22
    最近更新日期2014/02/25
    药物ATC编码
      • QI07AI02 live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira
    申请类型
    • TypeLevel1:[not specified]
    • TypeLevel2:[not specified]
    • TypeLevel3:[not specified]
    • TypeLevel4:[not specified]
    • TypeLevel5:[not specified]
    附件文件下载
      市场状态Positive
      ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase